Literature DB >> 21559832

Sequence and expression of the chicken membrane-associated phospholipases A1 alpha (LIPH) and beta (LIPI).

Manuela Hesse1, Edith Willscher, Benjamin J Schmiedel, Stefan Posch, Ralph P Golbik, Martin S Staege.   

Abstract

Cancer/testis antigens (CTA) are a heterogeneous group of antigens that are expressed preferentially in tumor cells and testis. Based on this definition the human membrane-associated phospholipase A1 beta (lipase family member I, LIPI) has been identified as CTA. The high homology of LIPI and the membrane-associated phospholipase A1 alpha (lipase family member H, LIPH) suggests that both genes are derived from a common ancestor by gene duplication. In contrast to human LIPI, human LIPH is expressed in several tissues. LIPI sequences have only been identified in mammals. Here, we describe the identification of LIPI in non-mammalian vertebrates. Based on the conserved genomic organization of LIPI and LIPH we identified sequences for both lipases in birds and fishes. In all vertebrates the LIPI locus is neighbored by a member of the RNA binding motif (RBM) family, RBM11. By sequencing of reverse transcriptase-polymerase chain reaction products we determined the sequences of LIPI and LIPH messenger RNA from broilers. We found that the sequence homology between LIPI and LIPH is much higher in non-mammalian species than in mammals. In addition, we found broad expression of LIPI in broilers, resembling the expression profile of LIPH. Our data suggest that LIPI is a CTA only in mammalian species and that the unique sequence features of the mammalian LIPI/RBM11 locus have evolved together with the CTA-like expression pattern of LIPI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21559832     DOI: 10.1007/s11033-011-0796-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  40 in total

1.  Mapping of the juxtacentromeric heterochromatin-euchromatin frontier of human chromosome 21.

Authors:  Christoph Grunau; Jérome Buard; Marie-Elisabeth Brun; Albertina De Sario
Journal:  Genome Res       Date:  2006-09-08       Impact factor: 9.043

2.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  Pierre van der Bruggen; Catia Traversari; Patrick Chomez; Christophe Lurquin; Etienne De Plaen; Benoît J Van den Eynde; Alexander Knuth; Thierry Boon
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

3.  A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma.

Authors:  Mitsuhiro Takenoyama; Jean-Françis Baurain; Manabu Yasuda; Tomoko So; Masakazu Sugaya; Takeshi Hanagiri; Kenji Sugio; Kosei Yasumoto; Thierry Boon; Pierre G Coulie
Journal:  Int J Cancer       Date:  2006-04-15       Impact factor: 7.396

4.  Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo.

Authors:  Bing Yang; Sean O'Herrin; Jianqiang Wu; Shannon Reagan-Shaw; Yongsheng Ma; Minakshi Nihal; B Jack Longley
Journal:  J Invest Dermatol       Date:  2006-09-07       Impact factor: 8.551

Review 5.  Structure and function of extracellular phospholipase A1 belonging to the pancreatic lipase gene family.

Authors:  Junken Aoki; Asuka Inoue; Kumiko Makide; Naoya Saiki; Hiroyuki Arai
Journal:  Biochimie       Date:  2006-10-27       Impact factor: 4.079

Review 6.  A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer.

Authors:  Mirjam T Epping; René Bernards
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

7.  Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: preclinical evaluation.

Authors:  Ulrich Wahl; Elfriede Nössner; Konrad Kronenberger; Rainer Gangnus; Heike Pohla; Martin S Staege; Hans-Jochem Kolb; Michael Hallek; Ralph Mocikat
Journal:  Clin Cancer Res       Date:  2003-09-15       Impact factor: 12.531

8.  Membrane-associated phospholipase A1 beta (LIPI) Is an Ewing tumour-associated cancer/testis antigen.

Authors:  Juergen L Foell; Manuela Hesse; Ines Volkmer; Benjamin J Schmiedel; Ingo Neumann; Martin S Staege
Journal:  Pediatr Blood Cancer       Date:  2008-08       Impact factor: 3.167

9.  Rapid evolution of cancer/testis genes on the X chromosome.

Authors:  Brian J Stevenson; Christian Iseli; Sumir Panji; Monique Zahn-Zabal; Winston Hide; Lloyd J Old; Andrew J Simpson; C Victor Jongeneel
Journal:  BMC Genomics       Date:  2007-05-23       Impact factor: 3.969

10.  A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Authors:  P G Coulie; V Brichard; A Van Pel; T Wölfel; J Schneider; C Traversari; S Mattei; E De Plaen; C Lurquin; J P Szikora; J C Renauld; T Boon
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  4 in total

1.  Lipase member H is a novel secreted protein associated with a poor prognosis for breast cancer patients.

Authors:  Meizi Cui; Haofan Jin; Xiumin Shi; Ge Qu; Lidi Liu; Xiaobo Ding; Yanbo Wang; Chao Niu
Journal:  Tumour Biol       Date:  2014-08-16

Review 2.  Comparative analyses of lysophosphatidic acid receptor-mediated signaling.

Authors:  Nobuyuki Fukushima; Shoichi Ishii; Toshifumi Tsujiuchi; Nao Kagawa; Kazutaka Katoh
Journal:  Cell Mol Life Sci       Date:  2015-03-04       Impact factor: 9.261

3.  Cell death-inducing DFFA-like effector c (CIDEC/Fsp27) gene: molecular cloning, sequence characterization, tissue distribution and polymorphisms in Chinese cattles.

Authors:  Jing Wang; Xiukai Cao; Hong Pan; Liushuai Hua; Mingjuan Yang; Chuzhao Lei; Xianyong Lan; Hong Chen
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

4.  Immunostimulation by OX40 Ligand Transgenic Ewing Sarcoma Cells.

Authors:  Dajana Reuter; Martin S Staege; Caspar D Kühnöl; Jürgen Föll
Journal:  Front Oncol       Date:  2015-10-27       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.